Summary
Both peptides fall into a similar broad context as Neuropeptides, although the details of how they are used and discussed still diverge. Their typical research and application settings separate fairly clearly: Selank is more often discussed in the realm of Neurology and brain health and Immunology and inflammation, whereas Setmelanotide is more often associated with the realm of Metabolic and endocrine. They also influence different molecular systems, with Selank tracking more closely to GPCR receptor while Setmelanotide centers more on Melanocortin receptor. Selank has a more synthetic analog origin, while Setmelanotide is closer to synthetic design background and their development context also differs, with Selank approved for Research use only while Setmelanotide is approved. Selank takes the form of a linear peptide, whereas Setmelanotide is closer to a cyclic peptide, Setmelanotide incorporates d-amino acid substitution features that are not part of Selank; while their sequence patterns also diverge, with Selank showing proline-rich features and Setmelanotide showing protein-mimetic sequence features.